Nyxoah (NASDAQ:NYXH) & DIH Holding US (NASDAQ:DHAI) Head to Head Review

DIH Holding US (NASDAQ:DHAIGet Free Report) and Nyxoah (NASDAQ:NYXHGet Free Report) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, profitability, valuation and dividends.

Profitability

This table compares DIH Holding US and Nyxoah’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
DIH Holding US -13.59% -5.07% -25.97%
Nyxoah -1,043.93% -51.68% -40.11%

Valuation and Earnings

This table compares DIH Holding US and Nyxoah”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
DIH Holding US $64.47 million 0.31 -$8.44 million ($0.30) -1.42
Nyxoah $5.08 million 66.35 -$46.77 million ($1.87) -5.29

DIH Holding US has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than DIH Holding US, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

DIH Holding US has a beta of -0.66, meaning that its share price is 166% less volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.41, meaning that its share price is 41% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for DIH Holding US and Nyxoah, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DIH Holding US 0 0 0 0 0.00
Nyxoah 0 0 5 0 3.00

Nyxoah has a consensus price target of $17.00, suggesting a potential upside of 71.72%. Given Nyxoah’s stronger consensus rating and higher probable upside, analysts clearly believe Nyxoah is more favorable than DIH Holding US.

Institutional & Insider Ownership

27.8% of DIH Holding US shares are held by institutional investors. 49.6% of DIH Holding US shares are held by insiders. Comparatively, 17.1% of Nyxoah shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

DIH Holding US beats Nyxoah on 9 of the 14 factors compared between the two stocks.

About DIH Holding US

(Get Free Report)

DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.

About Nyxoah

(Get Free Report)

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Receive News & Ratings for DIH Holding US Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIH Holding US and related companies with MarketBeat.com's FREE daily email newsletter.